Redmile Group logo

Redmile Group

North America, California, United States, San Francisco

Description

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

Investor Profile

Redmile Group has made 182 investments, with 14 in the past 12 months and 26% as lead.

Stage Focus

  • Series B (23%)
  • Post Ipo Equity (22%)
  • Series C (21%)
  • Series A (10%)
  • Series Unknown (9%)
  • Series D (7%)
  • Series E (3%)
  • Private Equity (2%)
  • Seed (1%)
  • Series F (1%)

Country Focus

  • United States (80%)
  • United Kingdom (6%)
  • Canada (3%)
  • France (3%)
  • Germany (2%)
  • Switzerland (2%)
  • Australia (2%)
  • Belgium (1%)
  • Sweden (1%)
  • China (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Health Diagnostics
  • Medical Device
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Redmile Group frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 21
OrbiMed
North America, New York, United States, New York
Co-Investments: 18
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 16
CA
North America, Massachusetts, United States, Boston
Co-Investments: 27
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 21
Casdin Capital
North America, New York, United States, New York
Co-Investments: 21
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 20
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 28
Invus
North America, New York, United States, New York
Co-Investments: 20
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 24

Which angels does Redmile Group often collaborate with?

SR
North America, California, United States, Los Angeles
Shared Deals: 1
PH
North America, Colorado, United States, Denver
Shared Deals: 1
TA
North America, Massachusetts, United States, Cambridge
Shared Deals: 1
LD
Europe, Vlaams-Brabant, Belgium, Leuven
Shared Deals: 1
MR
North America, California, United States, Hermosa Beach
Shared Deals: 1
JS
North America, California, United States, Palo Alto
Shared Deals: 1
ML
North America, California, United States, San Francisco
Shared Deals: 1
FN
North America, California, United States, Menlo Park
Shared Deals: 1
ER
North America, Massachusetts, United States, Boston
Shared Deals: 1
BH
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by Redmile Group?

Bambusa Therapeutics

Boston, Massachusetts, United States

Bambusa Therapeutics operates as biotechnology company.

BiotechnologyHealth CareLife ScienceMedical
Series AFeb 14, 2025
Amount Raised: $90,000,000
Abcuro

Newton, Massachusetts, United States

Abcuro develops immunotherapies to treat autoimmunity and cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series CFeb 12, 2025
Amount Raised: $200,000,000
Atara Biotherapeutics

South San Francisco, California, United States

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

BiotechnologyHealth CareOncologyTherapeutics
Post Ipo DebtJan 16, 2025
Amount Raised: $15,000,000
Clear Labs

San Carlos, California, United States

Clear Labs is a biotechnology firm that integrates a genomics system to simplify diagnostics for the clinical and application sectors.

Artificial Intelligence (AI)BiotechnologyHealth Diagnostics
Series DJan 13, 2025
Amount Raised: $30,000,000
Saluda Medical

Bloomington, Minnesota, United States

Saluda Medical is a commercial-stage medical device company that develops treatments for chronic neurological conditions.

Health CareMedicalMedical DeviceTherapeutics
Series UnknownJan 10, 2025
Amount Raised: $100,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $150,000,000
Scancell

Nottingham, Nottingham, United Kingdom

Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.

BiotechnologyHealth Care
Post Ipo EquityDec 6, 2024
Amount Raised: $14,400,720
Neurogene

New York, New York, United States

Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.

Biotechnology
Post Ipo EquityNov 4, 2024
Amount Raised: $200,000,000
Candid Therapeutics

San Diego, California, United States

Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.

BiotechnologyProduct ResearchTherapeutics
Series ASep 9, 2024
Amount Raised: $370,000,000
Oruka Therapeutics

Waltham, Massachusetts, United States

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

BiotechnologyHealth CareMedical
Post Ipo EquitySep 3, 2024
Amount Raised: $275,000,000